Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

hal-gatewood-_jbclosdsd4-unsplash

FDA approves new nonhormonal medication for menopause hot flashes

May 15, 2023 Medical Communications FDA, HRT, Veozah, hot flashes, menopause

The US Food and Drug Administration (FDA) has announced its approval of Veozah (fezolinetant), an oral medication to treat moderate …
News

FDA relaxes blood donation regulations for MSM

May 12, 2023 Medical Communications FDA, HIV, HIV/AIDS, blood donation

The US Food and Drug Administration (FDA) has released updated guidance for blood donation which relaxes the rules for donations …
News

Bellerophon Therapeutics completes phase 3 study for fibrotic interstitial lung disease drug

May 12, 2023 Medical Communications Bellerophon Therapeutics, Cardiology, clinical trial, lung disease

US clinical stage biotherapeutics company Bellerophon Therapeutics has announced that the last patient has completed its phase 3 REBUILD study, …
News

FDA advisory committee votes in favour of OTC contraceptive pill

May 11, 2023 Medical Communications Contraception, FDA, OTC, Perrigo, contraception

Perrigo Company has announced that the US Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) and the Obstetrics, …
News

Otsuka and Lundbeck gain FDA approval for supplemental New Drug Application for dementia drug

May 11, 2023 Medical Communications FDA, Lundbeck, Neurology, Otsuka Pharmaceuticals, alzheimer's disease, dementia

Japan-based healthcare company Otsuka Pharmaceutical and Danish pharma company Lundbeck have announced that the US Food and Drug Administration (FDA) …
News

AstraZeneca’s Ultomiris approved in EU for adults firm NMOSD

May 11, 2023 Medical Communications AstraZeneca, NMOSD, Neurology, Ultomiris, neurology

AstraZeneca has announced the approval of Ultomiris (ravulizumab) in the European Union (EU) for the treatment of adult patients with …
News

FDA pre-meeting report raises concerns over Sarepta’s gene therapy for Duchenne muscular dystrophy

May 11, 2023 Medical Communications Duchenne Muscular Dystrophy, FDA, Musculo-skeletal disorder, Sarepta Therapeutics, gene therapy

The US Food and Drug Administration (FDA) has released a report in preparation for its 12 May decision on Sarepta …
News

Sobi acquires CTI BioPharma Corporation for $1.7bn

May 10, 2023 Medical Communications CTI, acquisition, sobi

Swedish Orphan Biovitrum, aka Sobi, has announced that it had entered into a ‘plan of merger’ with CTI BioPharma Corp …
News

Thermo Fisher and Pfizer collaborate on NGS-based cancer tests

May 10, 2023 Medical Communications Cancer, NGS, Oncology, Pfizer, Thermo Fisher Scientifitic, oncology

Scientific equipment provider Thermo Fisher and US pharmaceutical firm Pfizer have announced a collaboration to advance next-generation sequencing (NGS)-based cancer …
News

Pharmacists in England given wider prescribing powers to relieve GP pressure

May 9, 2023 Medical Communications GP, NHS England, pharmacists

NHS England had announced that pharmacists in England will be given wider prescribing powers to relieve pressure put on GPs. …
News

AstraZeneca’s Farxiga approved to reduce risk of cardiovascular death

May 9, 2023 Medical Communications AstraZeneca, Cardiology, FDA, cvd, farxiga, heart failure

AstraZeneca has announced that the US Food and Drug Administration (FDA) has approved Farxiga to reduce the risk of cardiovascular …
News

CureVac and GSK begin phase 1 trial for mRNA flu vaccine candidates

May 9, 2023 Medical Communications CureVac, GSK, Virology, clinical trial, mrna, vaccines

CureVac and GSK have announced that the first patient in the phase 1 section of their combined phase 1/2 trial …
News
towfiqu-barbhuiya-6f2mpewg2ra-unsplash

FDA accepts sNDA for Optinose’s XHANCE

May 5, 2023 Medical Communications Ear Nose & throat, FDA, Nasal Spray, optinose, sNDA

Optinose has announced that the US Food and Drug Administration (FDA) has accepted a supplemental new drug application (sNDA) for …
News

Nanobiotix enters final contract negotiations with major pharma company

May 5, 2023 Medical Communications FDA, Oncology, nanobiotix, oncology

French late-stage clinical biotechnology company Nanobiotix has announced that it has entered into final contract negotiations with a major pharmaceutical …
News
robina-weermeijer-ihfopazzjhm-unsplash_5

Cognixion receives FDA Breakthrough Device Designation for assisted communication device

May 5, 2023 Medical Communications Cognixion, FDA, Neurology, brain computer interface, breakthrough device designation, neuroscience

Cognixion, a developer of non-invasive Brain-Computer Interface (BCI) and Augmented Reality (AR) technology, has announced that the US Food and …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026